COMP <GO>
TDOC vs HIMS // 10Y YIELD & FRED MACRO BETA
Teladoc Health Inc. (NYSE) VS. Hims & Hers Health Inc. (NYSE) • 15-METRIC TALLY: TDOC 4
— HIMS 7
▲ 10Y YIELD & FRED MACRO BETA LEADER: TDOC
LAST: $8.73 (+26.89%) • MKT CAP: $1.59B
macro-sensitivity
1.08
LAST: $29.67 (+1.19%) • MKT CAP: $6.92B
macro-sensitivity
1.05
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TDOC VS. HIMS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TDOC | HIMS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 73.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -17.00% | 8.40% | -25.40 | HIMS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 37.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 18.00% | 2.81% | +15.19 | TDOC | /fcf-yield <GO> |
| Operating Margin | -10.40% | 4.50% | -14.90 | HIMS | /operating-margins <GO> |
| Net Profit Margin | -7.90% | 5.50% | -13.40 | HIMS | /net-margins <GO> |
| Revenue Growth (YoY) | -1.50% | 59.00% | -60.50 | HIMS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.45 | 3.95 | -3.50 | HIMS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | HIMS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 79.0 | 53.1 | +25.90 | TDOC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.08 | 1.05 | +0.03 | TDOC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 32.0x | 45.3x | -13.30 | TDOC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.59B | $6.92B | -$5.34B | HIMS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TDOC REV | HIMS REV | TDOC GROSS % | HIMS GROSS % | TDOC FCF | HIMS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | $2.35B | — | 73.8% | $285.5M | $194.4M |
| FY 2024 | $2.57B | $1.48B | — | 79.5% | $282.9M | $184.6M |
| FY 2023 | $2.60B | $872.0M | — | — | $232.9M | $34.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TDOC // BETA 1.08
HIMS // BETA 1.05